Symptom improvement with mirabegron treatment is associated with urobiome changes in adult women

INTRODUCTION AND HYPOTHESIS: Mirabegron, a beta-3 agonist, is prescribed for urgency urinary incontinence (UUI). We assessed the correlation of symptom improvement with urobiome characteristics in adult women participants prescribed mirabegron for UUI treatment. METHODS: We enrolled participants see...

Descripción completa

Detalles Bibliográficos
Autores principales: Halverson, Thomas, Mueller, Elizabeth R., Brubaker, Linda, Wolfe, Alan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119880/
https://www.ncbi.nlm.nih.gov/pubmed/35412069
http://dx.doi.org/10.1007/s00192-022-05190-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119880/
https://www.ncbi.nlm.nih.gov/pubmed/35412069
http://dx.doi.org/10.1007/s00192-022-05190-w

Ejemplares similares